Neutrophil to lymphocyte ratio is a better indicator of COPD exacerbation severity in neutrophilic endotypes than eosinophilic endotypes

References

• Global Initiative for Chronic Obstructive Lung Disease [home page on Internet]Global Strategy for Diagnosis, Management, and Prevention of COPD (updated 2012) Available from: http://www.goldcopd.orgAccessed August 25, 2016
   Google Scholar
• KhilnaniGCBangaASharmaSKPredictors of mortality of patients with acute respiratory failure secondary to chronic obstructive pulmonary disease admitted to an intensive care unit: a one year studyBMC Pulm Med200441215566574
   PubMedGoogle Scholar
• SethiSMurphyTFInfection in the pathogenesis and course of chronic obstructive pulmonary diseaseN Engl J Med2008359222355236519038881
   PubMed Web of Science ®Google Scholar
• PapiABellettatoCMBraccioniFInfections and airway inflammation in chronic obstructive pulmonary disease severe exacerbationsAm J Respir Crit Care Med2006173101114112116484677
   PubMed Web of Science ®Google Scholar
• BafadhelMMcKennaSTerrySBlood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trialAm J Respir Crit Care Med20121861485522447964
   PubMed Web of Science ®Google Scholar
• BafadhelMDaviesLCalverleyPMBlood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysisEur Respir J201444378979124925917
   PubMed Web of Science ®Google Scholar
• PascoeSLocantoreNDransfieldMTBarnesNCPavordIDBlood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trialsLancet Respir Med20153643544225878028
   PubMed Web of Science ®Google Scholar
• BrightlingCEMcKennaSHargadonBSputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary diseaseThorax200560319319815741434
   PubMed Web of Science ®Google Scholar
• AgustíACelliBFanerRWhat does endotyping mean for treatment in chronic obstructive pulmonary disease?Lancet20173901009898098728872030
   PubMed Web of Science ®Google Scholar
• BrightlingCEBiomarkers that predict and guide therapy for exacerbations of chronic obstructive pulmonary diseaseAnn Am Thorac Soc201310Suppl214219
   Google Scholar
• GünayESarınç UlaşlıSNeutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective studyInflammation201437237438024078279
   PubMed Web of Science ®Google Scholar
• LacomaAPratCAndreoFValue of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2011615716921468168
   PubMed Web of Science ®Google Scholar
• TanrıverdiHÖrnekTErboyFComparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPDWien Klin Wochenschr201512719–2075676325586444
   PubMed Web of Science ®Google Scholar
• WangRTLiJYCaoZGLiYMean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary diseaseRespirology20131881244124823786593
   PubMed Web of Science ®Google Scholar
• YaoCLiuXTangZPrognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPDInt J Chron Obstruct Pulmon Dis201712122285229028814856
   PubMed Web of Science ®Google Scholar
• KöktürkNGürgünAŞenEThe View of Turkish Thoracic Society on the Report of the GOLD 2017 Global Strategy for the Diagnosis, Management and Prevention of COPDTurk Thorac J2017182576429404162
   PubMedGoogle Scholar
• VrijheidMThe exposome: a new paradigm to study the impact of environment on healthThorax201469987687824906490
   PubMed Web of Science ®Google Scholar
• Acartürk TunçayEKarakurtZAksoyEEosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation markerInt J Chron Obstruct Pulmon Dis201712123361337029200843
   PubMed Web of Science ®Google Scholar
• SaltürkCKarakurtZAdiguzelNDoes eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit?Int J Chron Obstruct Pulmon Dis201510101837184626392758
   PubMed Web of Science ®Google Scholar
• DumanDAksoyEAgcaMCThe utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophiliaInt J Chron Obstruct Pulmon Dis2015111024692478
   Google Scholar
• KarakurtZAksoyEDumanDEosinophilic COPD exacerbation: is there any difference in readmission, length of stay and mortality in the hospitalAm J Respir Crit Care Med2016193A5193
   Web of Science ®Google Scholar
• AgcaMCAksoyEDumanDDoes eosinophilia and neutrophil-to-lymphocyte ratio effect hospital re-admission in cases of COPD exacerbation?Am J Respir Crit Care Med2016193A6240
   Web of Science ®Google Scholar
• Vedel-KroghSNielsenSFLangePVestboJNordestgaardBGBlood eosinophils and exacerbations in chronic obstructive pulmonary disease. The Copenhagen General Population StudyAm J Respir Crit Care Med2016193996597426641631
   PubMed Web of Science ®Google Scholar
• SiddiquiSHGuasconiAVestboJBlood eosinophils: a biomarker of response to extrafine beclomethasone/formoterol in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2015192452352526051430
   PubMed Web of Science ®Google Scholar
• PavordIDLettisSLocantoreNBlood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPDThorax201671211812526585525
   PubMed Web of Science ®Google Scholar
• ForgetPKhalifaCDefourJPLatinneDvan PelMCde KockMWhat is the normal value of the neutrophil-to-lymphocyte ratio?BMC Res Notes20171011228057051
   PubMedGoogle Scholar
• BafadhelMMcKennaSTerrySAcute exacerbations of COPD: identification of biological clusters and their biomarkersAm J Respir Crit Care Med201118466267121680942
   PubMed Web of Science ®Google Scholar
• AnthonisenNRManfredaJWarrenCPHershfieldESHardingGKNelsonNAAntibiotic therapy in exacerbations of chronic obstructive pulmonary diseaseAnn Intern Med198710621962043492164
   PubMed Web of Science ®Google Scholar
• HurstJRDonaldsonGCPereraWRUse of plasma biomarkers at exacerbation of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2006174886787416799074
   PubMed Web of Science ®Google Scholar
• LeeSJLeeHRLeeTWUsefulness of neutrophil to lymphocyte ratio in patients with chronic obstructive pulmonary disease: a prospective observational studyKorean J Intern Med201631589189827017385
   PubMed Web of Science ®Google Scholar